Navigation Links
Enhanced Strategies for Design and Execution of Biomarker-driven Oncology Trials, new life science webinar hosted by Xtalks
Date:8/28/2013

(PRWEB) August 28, 2013

The stakes are high as a drug moves through clinical development — which accounts for more than 70% of the R&D cost needed to bring it to market. As the biopharmaceutical industry increasingly turns its focus to discovering and delivering targeted, personalized medicines, many of the old, well-tested strategies for developing cancer drugs are no longer relevant. Gaining access to patients in a clinical setting requires a new strategy, with biomarkers an integral part of the story.

This webinar — which features esteemed experts from Covance and M2Gen, part of the Moffitt Cancer Center — will focus on new ways to design biomarker driven trials and access the right patients. Speakers will demonstrate the power of the Total Cancer Care TM data warehouse.

A Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit: http://xtalks.com/strategies-biomarker-driven-oncology-trials.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/8/prweb11066612.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure
2. Evaluate Launches Enhanced Orphan Drug Intelligence
3. Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security
4. Cole-Parmer Offers Enhanced Selection of Centrifuges
5. Enhanced brain acetate metabolism may reward heavy drinkers
6. Pathway BioLogic is Chosen by Easy Gardener to Formulate the U.S.’s First Microbial Enhanced Natural Water Soluble Plant Food
7. BroadData Conferencing Announces Enhanced International Audio Conference Call Capabilities
8. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific Cell Culture Media Products Release
9. Synteract Unveils New Branding at DIA 2012 to Support Enhanced Commercial Strategy
10. Optimizing Assays from FFPE for Biomarker Strategies, New Life Science Webinar Hosted by Xtalks
11. Strategies for Rare Disease Studies and Orphan Drug Development in Europe; New Life Science Webinar Hosted by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... , May 23, 2016 - Leading ... 40% - Frontage Implement a Single Platform to Manage ... and Traceability Within the Bioanalytical lab Frontage Laboratories, a ... United States and China , has ... laboratory facilities. In addition to serving as the global electronic lab ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... molecular nanotechnology, announced the winners for the 2015 Foresight Institute Feynman Prizes. ... given in two categories, one for experiment and the other for theory in ...
(Date:5/20/2016)... San Diego, CA (PRWEB) , ... May 20, 2016 , ... ... announce that 10 of its most experienced veterinary clients have treated over 100 of ... this cutting edge technology to provide the highest level of care for their patients. ...
(Date:5/20/2016)... ... ... Korean researchers say Manumycin A triggers apoptosis, or natural cell death, in ... disease. Surviving Mesothelioma has just posted an article on the new study. Click ... mesothelioma study on the fact the Manumycin A, a derivative of Streptomyces parvulus, is ...
Breaking Biology Technology:
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):